- Home
- LIMN vs PUBM Comparison
LIMN vs PUBM Comparison
Compare LIMN & PUBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIMN
- PUBM
- Stock Information
- Founded
- LIMN 2018
- PUBM 2006
- Country
- LIMN United States
- PUBM United States
- Employees
- LIMN N/A
- PUBM N/A
- Industry
- LIMN
- PUBM Computer Software: Prepackaged Software
- Sector
- LIMN
- PUBM Technology
- Exchange
- LIMN NYSE
- PUBM Nasdaq
- Market Cap
- LIMN 623.8M
- PUBM 576.6M
- IPO Year
- LIMN N/A
- PUBM 2020
- Fundamental
- Price
- LIMN $16.60
- PUBM $11.44
- Analyst Decision
- LIMN
- PUBM Buy
- Analyst Count
- LIMN 0
- PUBM 11
- Target Price
- LIMN N/A
- PUBM $22.60
- AVG Volume (30 Days)
- LIMN 611.0K
- PUBM 554.7K
- Earning Date
- LIMN 01-01-0001
- PUBM 08-07-2025
- Dividend Yield
- LIMN N/A
- PUBM N/A
- EPS Growth
- LIMN N/A
- PUBM N/A
- EPS
- LIMN N/A
- PUBM 0.10
- Revenue
- LIMN N/A
- PUBM $288,380,000.00
- Revenue This Year
- LIMN N/A
- PUBM $2.70
- Revenue Next Year
- LIMN N/A
- PUBM $10.37
- P/E Ratio
- LIMN N/A
- PUBM $115.84
- Revenue Growth
- LIMN N/A
- PUBM 3.62
- 52 Week Low
- LIMN $4.40
- PUBM $7.46
- 52 Week High
- LIMN $33.66
- PUBM $22.99
- Technical
- Relative Strength Index (RSI)
- LIMN N/A
- PUBM 52.71
- Support Level
- LIMN N/A
- PUBM $10.84
- Resistance Level
- LIMN N/A
- PUBM $11.65
- Average True Range (ATR)
- LIMN 0.00
- PUBM 0.39
- MACD
- LIMN 0.00
- PUBM -0.06
- Stochastic Oscillator
- LIMN 0.00
- PUBM 48.39
About LIMN LIMINATUS PHARMA INC
Liminatus Pharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing cancer therapies and treatments. The GCC Vaccine of the company is in Phase II of clinical trials designed for immune behavior towards colorectal, pancreatic, gastric, and esophageal cancers that express Guanylyl Cyclase C.
About PUBM PubMatic Inc.
PubMatic Inc is a supply-side platform provider in the digital advertising technology market. These platforms help publishers, which supply digital ad inventory, manage their inventory, selling a high percentage of their inventory (increase the ad fill rate) and maximizing revenue per ad sold (optimize yield). The company generates revenue mainly by taking a piece of the ad sales that it enables. Buyers on the platform include intermediary buyers, such as demand-side platforms, or advertisers and ad agencies directly. Geographically, the company generates the majority of its revenue from the United States, followed by EMEA and APAC.